[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-435844-105":59,"doc-detail-435844-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","guidelines-for-parkinsons-disease-management-part-ii-consensus-from-the-movement-disorders-scientific-department-of-the-brazilian-academy-of-neurology-non-motor-symptoms","Guidelines for Parkinson’s disease management part II - consensus from the movement disorders scientific department of the Brazilian Academy of Neurology - non-motor symptoms","","Parkinson’s disease management is presented as highly individualized, requiring tailored recommendations for Brazilian practice. The Brazilian Academy of Neurology (ABN) developed guidance for treating non-motor symptoms through a specialist panel in movement disorders. Building on a prior article focused on motor symptoms, this part targets neuropsychiatric problems such as depression, anxiety, cognitive changes, and psychosis, and also addresses pain, sleep disorders, and dysautonomia with recommended therapies and medications. ",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/guidelines-for-parkinsons-disease-management-part-ii-consensus-from-the-movement-disorders-scientific-department-of-the-brazilian-academy-of-neurology-non-motor-symptoms/435844/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/guidelines-for-parkinsons-disease-management-part-ii-consensus-from-the-movement-disorders-scientific-department-of-the-brazilian-academy-of-neurology-non-motor-symptoms/435844.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-29",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of this Parkinson’s disease guideline part II?","Question",{"text":112,"@type":113},"It reports specialist recommendations for treating Parkinson’s disease non-motor symptoms in line with Brazilian needs and adapted evidence.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is this article connected to the earlier motor-symptoms guideline?",{"text":117,"@type":113},"It complements the first part published in 2022, which focused on motor symptoms, while this part focuses on non-motor symptoms.",{"name":119,"@type":110,"acceptedAnswer":120},"Which non-motor symptom areas does the guideline cover?",{"text":121,"@type":113},"It addresses neuropsychiatric symptoms such as depression, anxiety, cognitive alterations, and psychosis, as well as treatments for pain, sleep disorders, and dysautonomia.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},435844,1790790486,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Article published online: 2025-02-24  \nBrazilian Academy of Neurology 1  \nGuidelines for Parkinson’s disease management part II: consensus from the movement disorders scientific department of the Brazilian Academy of Neurology – non-motor symptoms  \nDébora Palma Maia 1 Rubens Gisbert Cury2 Pedro Renato P. Brandão3,4,5  \nFrancisco E. C. Cardoso6 Ana Paula Bertholo7 André Carvalho Felicio8 Arlete Hilbig9,10 Bruno Lopes Santos Lobato 11 Eline Rozária F. Barbosa5 Elizabeth Maria A. B. Quagliato 11 Gustavo H. C. Sousa 12 Jacy Bezerra Parmera7 Márcia Rúbia7 Marcus Vinícius Della Coletta 13 Maria Sheila Guimarães Rocha 14 Mariana Spitz 15 Mônica Haddad7 Nina Rosa A. F. Murta 1 Paulo Caramelli6 Raimundo N. D. Rodrigues 16 Ricardo Nitrini7 Roberto Prado 17  \nVitor Tumas 18 Ylmar Corrêa Neto 19 Roberta Arb Saba20,21  \n1 Universidade Federal de Minas Gerais, Hospital das Clínicas, Departamento de Neurologia, Belo Horizonte MG, Brazil.  \n2 Universidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Centro de Distúrbios do Movimento, São Paulo SP, Brazil.  \n3 Hospital Sírio Libanês, Brasília DF, Brazil.  \n4 Universidade de Brasília, Hospital da Universidade de Brasília, Brasília DF, Brazil.  \n5 Clínica Neurológica, Departamento de Saúde, Congresso Nacional, Brasília DF, Brazil.  \n6 Universidade Federal de Minas Gerais, Faculdade de Medicina, Departamento de Clínica Médica/Neurologia, Belo Horizonte MG, Brazil.  \n7 Universidade de São Paulo, Hospital das Clínicas, Departamento de Neurologia, São Paulo SP, Brazil.  \n8 Hospital Israelita Albert Einstein, São Paulo SP, Brazil.  \n9 Hospital São José, Porto Alegre RS, Brazil.  \n10 Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre RS, Brazil.  \n11 Universidade Federal do Pará, Laboratório de Neuropatologia Experimental, Belém PA, Brazil.  \nArq. Neuro-Psiquiatr. 2025;83(1):s00451802962 .  \nAddress for correspondence Débora Palma Maia ([email: maiadp@icloud.com](email: maiadp@icloud.com))  \n12 Hospital de Base do Distrito Federal, Brasília DF, Brazil.  \n13 Universidade do Estado do Amazonas, Departamento de Neurologia, Escola Superior de Ciências da Saúde, Manaus AM, Brazil.  \n14 Hospital Santa Marcelina, São Paulo SP, Brazil.  \n15 Universidade do Estado do Rio de Janeiro, Departamento de Neurologia, Rio de Janeiro RJ, Brazil.  \n16 Unidade de Sono de Brasília, Brasília DF, Brazil.  \n17 Universidade Federal de Sergipe, Faculdade de Medicina, Aracaju SE, Brazil.  \n18 Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Neurologia, Ribeirão Preto SP, Brazil.  \n19 Universidade Federal de Santa Catarina, Faculdade de Medicina, Departamento de Neurologia, Florianópolis SC, Brazil.  \n20 Universidade Federal de São Paulo, Departamento de Neurologia, Setor de Transtornos do Movimento, São Paulo SP, Brazil.  \n21 Hospital do Servidor Público Estadual de São Paulo, Serviço de Neurologia, Setor de Transtornos do Movimento, São Paulo SP, Brazil.  \nAbstract  \nKeywords  \n► Parkinson Disease  \n► Dementia  \n► Autonomic Nervous System Diseases  \n► Pain  \nThe treatment of Parkinson’s disease (PD) is a challenge, especially because it is considered highly individualized. The Brazilian Academy of Neurology (ABN) hasidentified the need to disseminate knowledge about its management, adapting the best evidence to the Brazilian population. The present article aims to report the recommendations for the treatment of non-motor symptoms of PD, developed by a group of specialists in movement disorders from the ABN ’s scientific department. In 2021, the first part, referring to the motor symptoms of PD, was published. The main non-motor symptoms were addressed—among them neuropsychiatric symptoms, such  \nreceived  \nAugust 5, 2024  \nreceived in its final form October 10, 2024 accepted  \nOctober 10, 2024  \nDOI [https://doi.org/](https://doi.org/)[ ](https://doi.org/)10.1055/s-0045-1802962 . ISSN 0004-282X  \nEditor-in-Chief: Hélio A. G. Teive.  \nAssociate Editor: Rena","cbCaivwzHMoO2JCJ","https://ap.wps.com/l/cbCaivwzHMoO2JCJ","pdf",801337,15,"English","# Introduction\n## Non-motor symptoms targeted by the guideline\n## Scope and relationship to the motor-symptoms part\n## Background: individualized treatment and ABN evidence adaptation","[{\"question\":\"What is the purpose of this Parkinson’s disease guideline part II?\",\"answer\":\"It reports specialist recommendations for treating Parkinson’s disease non-motor symptoms in line with Brazilian needs and adapted evidence.\"},{\"question\":\"How is this article connected to the earlier motor-symptoms guideline?\",\"answer\":\"It complements the first part published in 2022, which focused on motor symptoms, while this part focuses on non-motor symptoms.\"},{\"question\":\"Which non-motor symptom areas does the guideline cover?\",\"answer\":\"It addresses neuropsychiatric symptoms such as depression, anxiety, cognitive alterations, and psychosis, as well as treatments for pain, sleep disorders, and dysautonomia.\"}]","Guidelines for Parkinson’s disease management part II - consensus from the movement disorders scientific department of the Brazilian Academy of Neurology - non-motor symptoms | PDF",1790675559,38]